Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 2/20 | 0.37 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.37 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.37 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9964310 | 0.88 | P2RY2 (0.37) | P2RY2P2RY6P2RY14P2RY4TDP1 | |
| SCHEMBL12458446 | 0.81 | TDP1 (0.36) | P2RY2P2RY6P2RY14TDP1 | |
| SCHEMBL16594078 | 0.73 | TDP1 (0.42) | P2RY2P2RY6TDP1 | |
| SCHEMBL706579 | 0.71 | TDP1 (0.41) | P2RY2P2RY6P2RY14TDP1 | |
| SCHEMBL16863925 | 0.69 | TDP1 (0.34) | P2RY2P2RY6P2RY14TDP1 | |
| SCHEMBL9964294 | 0.69 | TDP1 (0.36) | P2RY2P2RY6P2RY14TDP1 | |
| SCHEMBL16604912 | 0.68 | SLC28A1 (0.33) | P2RY2P2RY6P2RY4 | |
| SCHEMBL9893207 | 0.67 | SLC28A1 (0.34) | P2RY2P2RY6P2RY14P2RY4TDP1 | |
| SCHEMBL1318516 | 0.65 | TDP1 (0.41) | P2RY2P2RY6P2RY14TDP1 | |
| SCHEMBL1317537 | 0.65 | TDP1 (0.36) | P2RY2P2RY6P2RY14TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9067961-B2 | Thiocarbon-protecting groups for RNA synthesis | AGILENT TECHNOLOGIES, INC. (US) | 2015-06-30 | — | — | US | disclosed |
| US-9067961-B2 | Thiocarbon-protecting groups for RNA synthesis | AGILENT TECHNOLOGIES, INC. (US) | 2015-06-30 | — | — | US | disclosed |
| US-20120238737-A1 | THIOCARBON-PROTECTING GROUPS FOR RNA SYNTHESIS | AGILENT TECHNOLOGIES, INC. (US) | 2012-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238737-A1 | THIOCARBON-PROTECTING GROUPS FOR RNA SYNTHESIS | NSUN3, NSUN2, TRDMT1 | P2RY2 2665/4885P2RY6 2787/4885P2RY14 3344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.